Research Article

Development of the Binary and Ternary Atorvastatin Solid Dispersions: In Vitro and In Vivo Investigations

Table 1

Composition of samples and the dissolution efficiencies (DE30).

FormulationComponent ratioDE (%) ()
ATRPEG 4000PEG 10000Poloxamer 188

ATR1
BS111
BS213
BS315
BS417
BS511
BS613
BS715
BS817
PMB715
BS911
BS1013
BS1115
PMB911
TS1151
TS2153
TS3155
PMT1151

B: binary; T: ternary; S: solid dispersion; PM: physical mixture.